


The Fund aims to achieve above average capital growth.
| Name | % Net Assets |
|---|---|
| Apple Inc. | 8.0% |
| Oracle Corp. | 3.8% |
| JPMorgan Chase & Co. | 3.6% |
| Wells Fargo & Co. | 3.4% |
| Blackstone Group L.P. | 3.0% |
| DaVita Inc. | 3.0% |
| Pfizer Inc. | 3.0% |
| Airgas Inc. | 2.9% |
| Crown Castle International Corp. | 2.5% |
| Amgen Inc. | 2.5% |
| Key | % Net Assets |
|---|---|
| 8.0% | |
| 3.8% | |
| 3.6% | |
| 3.4% | |
| 81.2% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 739.68p |
| Currency | GBP |
| Change | -2.62p |
| % | -0.35% |
| YTD change | -34.77p |
| YTD % | -4.49% |
| Fund Inception | 31/03/1982 |
|---|---|
| Fund Manager | Cormac Weldon |
| TER | 1.04 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | -0.04 |
You are here: research